The French government recently warned that it is related to implants used for breast augmentation and specialized lymphomas (undifferentiated large cell lymphoma, Anaplastic large cell lymphoma (abbreviated as ALCL) in English) in breasts became.
Currently it is a very rare tumor and the prognosis is better than the lymphoma that occurs in the whole body so it is not a recommendation for patients who have done breast implants immediately. ALCL is a T cell type tumor called non-Hodgkin’s lymphoma, and there are about 60 cases reported in the world about localized breasts, but it is said that there are more than tens of millions of patients receiving a breast augmentation surgery Because it is so, it is extremely rare.
However, in Europe and the United States there is a system to make information disclosure early and the FDA also keeps monitoring on this subject.